About this paper
The business of life sciences R&D is fundamentally shifting – from a primary focus on regulatory approval to a broader view on widespread adoption by providers and payers… from showing the value of treatments in controlled, isolated clinical settings to proving it in large target populations and real world conditions. The opportunity is at hand to gain insights from tens of thousands of patients, as opposed to the limited population of a clinical trial.
This paper describes the technology building blocks that deliver this type of insight: a common data model, fit-for-purpose analytical applications, user-friendly interfaces and high-performance computing that delivers answers on the fly from big data.
SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.